Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
about
Nanomedicines based on recombinant fusion proteins for targeting therapeutic siRNA oligonucleotides.Progress toward in vivo use of siRNAs-IISilencing disease genes in the laboratory and the clinicSynthesis of lipid-oligonucleotide conjugates for RNA interference studies.Silencing early viral replication in macrophages and dendritic cells effectively suppresses flavivirus encephalitis.Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo.Ago-2-mediated slicer activity is essential for anti-flaviviral efficacy of RNAi.Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects.Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study.RNA interference for improving the outcome of islet transplantation.Targeting DNA vaccines to myeloid cells using a small peptide.A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiencyIncreased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gelsSystemic Administration of siRNA via cRGD-containing Peptide.Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells.Silencing tumor necrosis factor-alpha in vitro from small interfering RNA-decorated titanium nanotube array can facilitate osteogenic differentiation of mesenchymal stem cellsHuman macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model.Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammationThe controversial role of microglia in malignant gliomas.Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapyDelivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarctionSilencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice.Macrophages heterogeneity in atherosclerosis - implications for therapy.Peptide- and Amine-Modified Glucan Particles for the Delivery of Therapeutic siRNA.Disruption of tumour-host communication by downregulation of LFA-1 reduces COX-2 and e-NOS expression and inhibits brain metastasis growth.SiRNA Crosslinked Nanoparticles for the Treatment of Inflammation-induced Liver Injury.Acid-Sensitive Sheddable PEGylated PLGA Nanoparticles Increase the Delivery of TNF-α siRNA in Chronic Inflammation Sites.Bone marrow-targeted liposomal carriersRNAi-based therapeutic strategies for metabolic disease.The executioners sing a new song: killer caspases activate microglia.Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.A daunting task: manipulating leukocyte function with RNAi.Novel RNA interference-based therapies for sepsis.Advances in targeted delivery of small interfering RNA using simple bioconjugates.Drug Trafficking into Macrophages via the Endocytotic Receptor CD163.Pulmonary Delivery of siRNA via Polymeric Vectors as Therapies of AsthmaPotential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges.Rabies vaccine development by expression of recombinant viral glycoprotein.Delivery of siRNA using ternary complexes containing branched cationic peptides: the role of peptide sequence, branching and targeting.Systemic and tumor-targeted delivery of siRNA by cyclic NGR and isoDGR motif-containing peptides.
P2860
Q27692125-5DDBD6EF-A980-4D2E-A4FD-A6B5D468A990Q28255877-74B8FA94-78A7-4447-974D-2609C38615B1Q29039090-598B403B-41C5-4DD3-8C55-3B85439E9645Q33825496-1C3702CA-C3E3-4AD4-8F39-A616E5BC6241Q33851384-0DEF2372-2379-4BF3-9B4C-E9769F079014Q33924645-38BD8C48-DDE8-429B-A012-00A26A839949Q34079328-2A05F9C3-40C2-4B35-95F0-21D349A946C7Q34095999-D8618AAF-EC67-4FD8-8AE9-4FDFB6762EE4Q34190582-3BC0D392-6EE6-44B3-A7F6-B9F104FCAA82Q34729434-462D492A-697D-435D-9EDC-862E039D1181Q34943809-D0577BA8-F732-4535-BED3-FE9DEFEEFBBDQ35298225-88C01364-4E19-4A29-9976-9872529933A1Q35846848-C3168B32-F0CB-4AAD-A31A-8EBF9DB58FC9Q35989535-3CC4D001-AFCD-4731-B48E-2D78171A192CQ36053809-03A7F4AD-CB85-4808-AFA4-C4ABF6D1F97FQ36091401-EBDF0130-6239-4425-AECD-5BE9981D9541Q36485210-65131132-AF1A-4679-B884-FB02D1CA392EQ36813784-9A2EA540-FB62-4375-9E9D-4A395E0FA055Q37091110-2D7D7963-49B7-4BF4-84AB-BDD1EF567641Q37146028-C77EB821-E561-4ADA-8AB7-C6B0B057BA08Q37155836-C7F4FC42-83D6-4C6E-AC4A-C4C15EA4BA3CQ37234557-1F17E6A3-ABC1-4BC2-8054-FFEF30FFFB08Q37294955-877A85B7-1B82-4F1D-A31C-4AEDF97F760FQ37498037-1CD292C2-4E5D-4AF0-8C58-E698EE1E6CC3Q37588467-86037963-9C09-4902-A43C-8D7A5D707294Q37662854-97A7A04C-A542-44AF-99E9-EE28E174A4DAQ37672324-1337ADAB-86AA-4E1C-90F4-DF53D0ACD30BQ37833107-B3558673-21E5-4829-9DE6-8DAF63E3DE95Q37866632-BF9DCD05-6BAC-4547-A8E4-F87955425CDFQ37916221-05E3D866-9907-49E6-A6BF-99D90CAF64DBQ37944929-5CEDA61E-ACB8-4249-934D-B31881642B3DQ38095502-4E7BBF02-6828-49F4-8808-CEE37DAD80F7Q38176441-233630A9-193B-447B-B1FC-ECF220370D0CQ38199518-A114DBAE-1C4D-4841-B092-40116F9761C9Q38537751-305BD45C-CB8F-465C-B546-95B2B226CB1AQ38543206-B89545D9-D45F-4AE3-930E-50E8E8394BA7Q38544126-D4A47DE0-59E9-4FFD-9BBC-C75E8520C19CQ38735052-D7E594B1-6468-4688-A734-65A1F8B2D8B2Q38801023-0E8B89AE-18B1-494A-9B2C-9F24C3EB3C1AQ38801839-AD456138-23BE-4580-B8E6-A8B419ABB347
P2860
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
@en
type
label
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
@en
prefLabel
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
@en
P2093
P2860
P356
P1433
P1476
Targeted delivery of siRNA to macrophages for anti-inflammatory treatment.
@en
P2093
Chunting Ye
Haoquan Wu
Isaac Chiu
N Manjunath
Premlata Shankar
Priti Kumar
Sandesh Subramanya
Sang-Soo Kim
P2860
P304
P356
10.1038/MT.2010.27
P577
2010-03-09T00:00:00Z